While the abundance of TFR1 impacts colorectal cancer cell proliferation rates [96], this is particularity appealing for engineering nanoparticles in CRC-targeted therapy by surface functionalization with TFR’s natural ligand transferrin [97,98,99,100]. This evidence concerns the gene TFRC and colorectal cancer.